Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis
Part of paid clinical trials in Belmont, Massachusetts.
- Sponsor
- Mclean Hospital
- Study ID
- NCT07503093
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Anxiety
- Depression
- Psychosis
- Rumination
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- Smartphone-based Mindfulness Exercise — BEHAVIORALA brief approximately 1 minute video guided mindfulness based breathing exercise designed to anchor attention to the present moment and reduce negative affect in the moment by guiding participants through a structured breathing technique.
- Smartphone-based Psychoeducation — BEHAVIORALA brief text or video based psychoeducation message delivered via the smartphone app. Content covers the nature of emotions and emotion regulation strategies, aimed at improving emotional awareness and coping skills in the moment.
- Neutral Control Message — BEHAVIORALA brief text or video based message containing random facts delivered via the MetricWire smartphone app. This serves as an active control condition to allow comparison with the active intervention conditions.
Study Details
The aim of this trial is to evaluate the feasibility and preliminary efficacy of using passive smartphone sensors to detect moments of heightened negative mood and inform the timing of brief mental health interventions, such as mindfulness exercises and psychoeducation, in adults with early psychosis.
Key Dates
- Start date
- May 1, 2026
- Status verified
- Apr 2026
- Primary completion
- May 1, 2027
- Completion
- Jun 1, 2027
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Other: Within-Person Micro-randomizationEach participant is randomized four times per day to receive one of four conditions with equal probability (33.3% each): a mindfulness exercise, psychoeducation, a neutral control message. A brief EMA is completed before and after each randomization event to measure proximal changes in mood (sadness, anxiety, irritability, stress, rumination).
Primary Outcome Measure
Retention Rate [ Time Frame: 10 weeks ]
Central Contacts
- Yoonho Chung, PhD617-855-2854
- Justin T Baker, MD, PhD617-855-3913
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| McLean Hospital | Belmont | Massachusetts | 02478 | - |
Find similar trials in Belmont, MA
By condition
By specialty
By research site
Related Studies
- Brain Connectivity in DepressionRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Buspirone and Melatonin for Depression Following Traumatic Brain InjuryPHASE4 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- Mechanisms and Predictors of Change in App-Based Mindfulness Training for AdolescentsRecruiting · Mclean Hospital · Belmont, Massachusetts
- Early Life Stress and Depression: Molecular and Functional ImagingRecruiting · Mclean Hospital · Belmont, Massachusetts